News Home

Will aTyr Pharma Inc (LIFE) Outperform the Rest of the Stocks in the Healthcare Sector?

Friday, October 01, 2021 02:20 PM | InvestorsObserver Analysts
Will aTyr Pharma Inc (LIFE) Outperform the Rest of the Stocks in the Healthcare Sector?

aTyr Pharma Inc (LIFE) is around the top of the Healthcare sector according to InvestorsObserver. LIFE received an overall rating of 61, which means that it scores higher than 61% of stocks. Additionally, aTyr Pharma Inc scored a 99 in the Healthcare sector, ranking it higher than 99% of stocks in that sector.

Overall Score - 61
LIFE has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on LIFE!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With aTyr Pharma Inc Stock Today?

aTyr Pharma Inc (LIFE) stock is down -5.29% while the S&P 500 has risen 1.07% as of 2:18 PM on Friday, Oct 1. LIFE has fallen -$0.48 from the previous closing price of $9.08 on volume of 343,013 shares. Over the past year the S&P 500 has risen 28.77% while LIFE has risen 162.20%. LIFE lost -$2.29 per share the over the last 12 months. Click Here to get the full Stock Report for aTyr Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App